Effect of physicochemical variables of regular insulin formulations on their absorption from the subcutaneous tissue

Diabetes Research and Clinical Practice

Volumn 40, Issue 1, 1998, Pages 39-44

  Polaschegg, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Diabetes mellitus; Insulin absorption; Insulin therapy; Treatment

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; INSULIN LISPRO; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG FORMULATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN CLEARANCE; INSULINEMIA; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SUBCUTANEOUS TISSUE; TEMPERATURE;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; REFERENCE VALUES; SKIN ABSORPTION;

EID: 0031819834     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00021-7     Document Type: Article

References (13)

1. Kang S., Brange J., Burch A., Volund A., Owens D.R. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans. Diabetes Care. 14:1991;942-947.
2. Barnett A.H., Owens D.R. Insulin analogues. Lancet. 349:1997;47-51.
3. Chantelau E., Sonnenberg G.E., Rajab A., Römisch J., Berger M. Absorption of subcutaneously administered regular human and porcine insulin in different concentrations. Diabete Metabol. 11:1985;106-110.
4. Sindelka G., Heinemann L., Berger M., Frenck W., Chantelau E. Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia. 37:1994;377-380.
5. Wach P., Trajanowski Z., Kotanko P., Skrabal F. Numerical approximation of mathematical model for absorption of subcutaneously injected insulin. Med. Biol. Eng. Comput. 33:1995;18-23.
6. Kubota M., Lougheed W.D., Carson S.M., Albisser A.M. The pharmacokinetics of diluted intermediate acting insulin: Studies in an animal model. Diabetes Nutr. Metab. 2:1989;99-103.
7. Periello G., Torlone E., Di Santo S., Fanelli C., De Feo P., Santeusanio F., Brunetti P., Bolli G. Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with Type-1(insulin-dependent) diabetes mellitus. Diabetologia. 31:1988;811-815.
8. Berger M., Cüpper H.J., Hegner H., Jörgens V., Berchtold P. Absorption kinetics and biologic effects of subcutaneously injected insulin. Diabetes Care. 5:1982;77-91.
9. Heinemann L., Heise T., Wahl L.C., Trautmann M.E., Ampudia J., Starke A.A.R., Berger M. Prandial glycaemia after a carbohydrate-rich meal in type-1 diabetic patients: using the rapid acting insulin analogue (Lys(B28),Pro(B29)) human insulin. Diabetic Med. 13:1996;625-629.
10. Berger M., Heinemann L. Are presently available insulin analogues clinically beneficial? Diabetologia. 40(Suppl. 1):1997;S91-S96.
11. Chantelau E., Heinemann L. Insulin analogues - not faster than U40 regular human insulin? Diabetes Res. Clin. Pract. 21:1993;201-202.
12. Heinemann L., Weyer C., Rave K., Stiefelhagen O., Rauhaus M., Heise T. Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp. Exp. Clin. Endocrinol. Diabetes. 105:1997;140-144.
13. Turnheim K., Waldhäusl W.K. Essentials of insulin pharmacokinetics. Wien. Klin. Wochenschr. 100:1988;65-87.